Abstract
Nosologically, Alzheimer disease (AD) is no one single disorder. Evidence is provided that a small proportion of 5% to 10% of all Alzheimer cases is caused by missense mutations in presenilin 1 or 2 genes on chromosomes 14 and 1, or in APP gene on chromosome 21 leading to autosomal dominant familial AD with early onset. This difference of inheritance serves as the basis of the amyloid cascade hypothesis which is limited to the above mutations. The latter hypothesis explains the increased formation of the APP derivative βA4 which aggregates to amyloid (Hardy and Selkoe, 2002). However, in constrast, the great majority of all Alzheimer cases (95% to 90%) was found to be sporadic in origin and of late onset. βA4 has not been proven to be necessary for the generation and the development of this neurodegenerative disorder (Joseph et al., 2001). Thus, the amyloid cascade hypothesis may not be accepted for sporadic Alzheimer disease (SAD). Instead, susceptibility genes may contribute to the onset of the latter type of AD. Best known are allelic abnormalities on the APOE-gene on chromosome 19 responsible for both anticipated onset and increase in severity of both inherited and sporadic AD. Candidate susceptibility genes for SAD are assumed to be on chromosomes 4, 6, 10 and 20 (Bertram et al., 2000a; Pericak-Vance et al., 2000). Other candidate genes did not show any association or linkage with AD (Bertram et al., 2000b).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Adamo, M., Raizada, M.K., and LeRoith, D., 1989, Insulin and insulin-like growth factor receptors in the nervous system, Mol. Neurobiol. 3:71–100.
Amri, H., Ogwuegbu, S.O., Boujard, N., Drieu, K., and Papadopoulos, V., 1996, In vivo regulation of the peripheral-type benzodiazepine receptor and glucocorticoid synthesis by the Ginkgo biloba extract EGb 761 and isolated ginkgolides, Endocrinology 137:5707–5718.
Bak, P., Tang, C. and Wiesenfeld, K., 1988, Self-organized criticality, Phys. Rev. A38:365–374.
Baskin, D.S. Browning, J.L., Pirozzolo, F.J., Korporaal, S., Baskin, J.A., and Appel, S.H., 1999, Brain choline acetyltransferase and mental function in Alzheimer disease, Arch. Neurol. 56:1221–1223
Baskin, D.G., Schwartz, M.W., Sipols, A.J., D’Alessio, DA., Goldstein, B.J., and White, M.F., 1994, Insulin receptor substrate-1 (IRS-1) expression in rat brain, Endocrinology 134:1952–1955
Benzi, G., Pastoris, I., Villa, R.F., and Giuffrida-Stella, A.M., 1984, Effect of aging on cerebral cortex energy metabolism in hypoglycemia and posthypoglycemic recovery, Neurobiol. Aging 5:205–212.
Bertram, L., Blacker, D., Mullin, K., Keeny, D., Jones, J., Basu, S., Yhu, S. Mclnnis, M.G., Go, R.C.P., Vekrellis, K. et al., 2000a, Evidence for genetic linkage of Alzheimer’s disease to chromosome 10q, Science 290:2302–2303.
Bertram, L., Blacker, D., Crystal, A., Mullin, K., Kenney, D., Jones, J., Basu, S., Yhu, S., Guenette, S., Mclnnis, M., et al., 2000b, Candidate genes showing no evidence for association or linkage with Alzheimer’s disease using family-based methodologies, Exp. Gerontol. 35:1353–1361.
Biagini, G., Pich, E.M., Carani, C, Manama, P., and Agnati, L., 1998, Postnatal maternal separation during the stress hyporesponsive period enhances the adrenocortical response to novelty in adult rats by affecting feedback regulation in the CA1 hippocampal field, Int. J. Devi. Neurosci. 16:187–197.
Bigl, V., Arendt, T., Fischer, S., Werner, M., and Arendt, A., 1987, The cholinergic system in aging, Gerontology 33:172–180.
Bowen, D.M., 1984, Cellular aging: selective vulnerability of cholinergic neurons in human brain, Monogr. Dev. Biol. 17:42–59.
Braakman, J., Helenius, J., and Helenius, A., 1992, Role of ATP and disulfide bonds during protein folding in the endoplasmic reticulum, Nature 356:260–262.
Brown, G.G. Levine, S.R., Gorell, J.M., Pettegrew, J.W., Gdowksi,, J.E., Bueri, J.A. Helpern, J.A., and Welch, K.M.A., 1989, In vivo 31P-NMR profiles of Alzheimer disease and multiple subcortical infarct dementia, Neurology 39:1423–1427.
Bush, M.L., Niyashiro, J.S., and Ingram, V.M., 1995, Activation of a neurofilament kinase, a tau kinase and tau phosphatase by decreased ATP levels in nerve growth factor-differentiated PC12 cells, Proc. Natl. Acad. Sci. USA 92:1962–1965.
Buttgereit, F., and Brand, M.D., 1995, A hierarchy of ATP-consuming processes in mammalian cells, Biochem. J. 312:163–167.
Cho, K.S., Choi, J., Ha., CM., Son, Y.J., Choi, W.S., and Lee, B.K., 2002, Comparison of gene expression in old versus young rat hippocampus by cDNA array, Neuro Report 13:285–289.
Cizza, G., Calogero, A.E., Brady, L.S., Bagdy, G., Bergamini, E., Blackmail, M.R., Chrousos, G.P., and Gold, P.W., 1994, Male Fischer 344/N rats show a progressive central impairment of the hypothalamic-pituitary-adrenal axis with advancing age, Endocrinology 134:1611–1620.
D’Andrea, M.R., Nagele, R.G., Wang, H.-Y., Peterson, P.A., and Lee, D.H.S., 2001, Evidence that neurones accumulating amyloid can undergo lysis to form amyloid plaques in Alzheimer’s disease, Histopathology 38:120–134.
Davidsson, P., Blennow, K., Andreasen, N., Eriksson, B., Minthon, L., and Hesse, C, 2001, Differential increase in cerebrospinal fluid-acetylcholinesterase after treatment with acetylcholinesterase inhibitors in patients with Alzheimer’s disease, Neurosci. Lett. 300:157–160.
Demaurex, N., Furuya, W., D’Souza, S., Bonifacino, J.S., and Grinstein, S., 1998, Mechanism of acidification of the trans-Golgi network (TGN). In situ measurements of pH using retrieval of TGN 38 and furin from the cell surface, J. Biol. Chem. 273:2044–2051.
Devaskar, S.U., Giddings, S.J., Rajakumar, P.A., Camaghi, L.R., Menon, R.K., and Zahn, D.S., 1994, Insulin gene expression and insulin synthesis in mammalian neuronal cells, J. Biol. Chem. 269:8445–8454.
Dorner, A.J., Wasley, L.C., and Kaufman, R.J., 1990, Protein dissociation from GRP 78 and secretion are blocked by depletion of cellular ATP levels, Proc. Natl. Acad. Sci. USA 87:7429–7432.
Duara, R., Grady, C., Haxby, J., Sundaram, S., Cutler, N.R., Heston, L., Moore, A., Schlageter, N., Larson, S., and Rapoport, S.I., 1986; Positron emission tomography in Alzheimer’s disease, Neurology 36:879–887.
Duelli,R.,Schröck,H., Kuschinsky,W., and Hoyer,S., 1994, Intracerebroventricular injection of streptozotocin induces discrete local changes in cerebral glucose utilization in rats, Int. J. Devl. Neurosci. 12:737–743.
Eckert, G.P., Cairns, N.J., Maras, A., Gattaz, W.F., and Muller, W.E., 2000, Cholesterol modulates the membrane-disordering effects of beta-amyloid peptides in the hippocampus: specific changes in Alzheimer’s disease, Dementia Geriatr. Cogn. Disord. 11:181–186.
Erecinska, M., and Silver, I.A., 1989, ATP and brain function, J. Cereb. Blood Flow Metab. 9:2–19.
Foster, N.L., Chase, T.N., Mansi, L., Brooks, R., Fedio, P., Patronas, N.J. and DiChiro, G., 1984, Cortical abnormalities in Alzheimer’s disease, Ann. Neurol. 16:649–654.
Frölich, L., Blum-Degen, D., Bernstein, H.G., Engelsberger, S., Humrich, J., Laufer, S., Muschner, D., Thalheimer, A., Türk, A., Hoyer, S., et al., 1998, Insulin and insulin receptors in the brain in aging and sporadic Alzheimer’s disease, J. Neural Transm. 105:423–438.
Fukuyama, H., Ogawa, M., Yamauchi, H., Yamaguchi, S., Kimura, J., Yonekura, Y., and Konishi, J., 1994, Altered cerebral energy metabolism in Alzheimer’s disease: a PET study, J. Nucl. Med. 35:1–6.
Garland, P.B., and Randle, P.J., 1965, Control of pyruvate dehydrogenase in the perfused rat heart by the intracellular concentration of acetyl-coenzyme A, Biochem. J. 91:76C–77C
Gasparini, L., Gouras, K.G., Wang, R., Gross, R.S., Beal, M.F., Greengard, P., and Yu, H., 2001, Stimulation of β-amyloid precursor protein trafficking by insulin reduces intraneuronal β-amyloid and requires mitogen-activated protein kinase signaling, J. Neurosci. 21:2561–2570.
Gerozissis,, R., Rouch, C, Lemierre, S., Nicolaidis, S., and Orosco, M., 2001, A potential role of central insulin in learning and memory related to feeding, Cell. Mol. Neurobiol. 21:389–401.
Gething, M.-J., and Sambrook, J., 1992, Protein folding in the cell, Nature 355:33–45.
Gething, M.-J., McCammon, K., and Sambrook, J., 1986, Expression of wild-type and mutant forms of influenza hemagglutinin: the role of folding in intracellular transport, Cell 46:939–950.
Gibson, G.E., Jope, R., and Blass, J.P., 1975, Decreased synthesis of acetylcholine accompanying impaired oxidation of pyruvic acid in rat brain minces, Biochem. J. 148:17–23.
Gibson, G.E., Petersen, C., and Jenden, D.J., 1981, Brain acetylcholine synthesis declines with senescence, Science 213:674–676.
Giorgino, F., Almahfouz, A., Goodyear, L.J., and Smith, R.J., 1993, Glucocorticoid regulation of insulin receptor and substrate IRS-1 tyrosine phosphorylation in rat skeletal muscle in vivo, J. Clin. Invest. 91: 2020–2030.
Goldstein, B.J., 1993, Regulation of insulin receptor signaling by protein-tyrosine dephosphorylation, Receptor 3:1–15.
Gouras, G.K., Tsai, J., Naslund, J., Vincent, B., Edgard, M., Greenfield, J.P., Haroutunian, V., Buxbaum, J.S., Xu, H., Greengard, P., and Relkin, N.R., 2000, Intraneuronal βA42 accumulation in human brain, Am. J. Pathol. 156:15–20.
Hammond, C., and Helenius, A., 1994, Quality control in secretory pathway: retention of a misfolded viral membrane glycoprotein involves cycling between the ER, intermediate compartment, and Golgi apparatus, J. Cell Biol. 126:41–52.
Hamos, J.E. Oblas, B., Pulaski Salo, D., Welch, W.J., Bole, D.G., and Drachman, D.A. 1991, Expression of heat shock proteins in Alzheimer’s disease, Neurology 41:345–350.
Häring, H.U., 1991, The insulin receptor: signalling mechanism and contribution to the pathogenesis of insulin resistance, Diabetologica 34:848–861.
Hardy, J., and Selkoe, D.J., 2002, The amyloid hypothesis of Alzheimer’s disease: Progress and problems on the road to therapeutics, Science 297:353–356.
Harik, S.I., and McCracken, K.A., 1986, Age-related increase in presynaptic noradrenergic markers of the rat cerebral cortex, Brain Res. 381:125–130.
Hawkins, R.A., Mans, A.M., Davis, D.W., Hibbard, L.S., and Lu, D.M., 1983, Glucose availability to individual cerebral structures is correlated to glucose metabolism, J. Neurochem. 40:1013–1018.
Hayashi, A., Nagaoka, M., Yamada, K., Ichitani, Y., Miake, Y., and Okado, N., 1998, Maternal stress induces synaptic loss and developmental disabilities of offspring, Int. J. Devl. Neurosci. 16:209–216.
Held, G.A., Solina, D.H., Keane, D.T., Haag, W.J., Horn, P.M., and Grinstein, G., 1990, Experimental study of critical-mass fluctuations in an evolving sandpile. Physic. Rev. Lett. 69:1120–1123.
Henneberg, N., and Hoyer, S., 1995, Desensitization of the neuronal insulin receptor: a new approach in the etiopathogenesis of late-onset sporadic dementia of the Alzheimer type (SDAT)?, Arch. Gerontol. Geriatr. 21:63–74.
Herholz, K., Salmon, E., Perani, D., Baron, J.-C, Holthoff, V., Frölich, L., Schönknecht, P., Ito, K., Mielke, R., Kalbe, E., et al., 2002, Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET, Neurolmage 17:302–316.
Hess, B., 1983, Non-equili brium dynamics of biochemical processes, Hoppe-Seylers Z. Physiol. Chem. 364:1–20.
Hess, B., 1990, Order and chaos in chemistry and biology, Fresenius J. Anal. Chem. 337:459–468.
Holness, M.J., Langdown, M.L., and Sugden, M.C., 2000, Early-life programming of susceptibility to dysregulation of glucose metabolism and the development of typ 2 diabetes mellitus, Biochem. J. 349:657–665.
Hong, M., and Lee, V.M.Y., 1997, Insulin and insulin-like growth factor-1 regulate tau phosphorylation in cultured human neurons, J. Biol. Chem. 272:19547–19553.
Horner, H.C., Packan, D.R., and Sapolsky, R.M., 1990, Glucocorticoids inhibit glucose transport in cultured hippocampal neurons and glia, Neuroendocrinology 52:57–64.
Hotamisligil, G.A., Murray, D.L., Choy, L.N., and Spiegelman, B.M., 1994, Tumor necrosis factor a inhibits signaling from the insulin receptor, Proc. Natl. Acad. Sci. USA 91:4854–4858.
Hotamisligil, G.S., Peraldi, P., Budavari, A., Ellis, R., White, M.F., and Spiegelman, B.M., 19%, IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α-and obesity-induced insulin resistance, Science 271:665–668.
Hoyer, S., 1985, The effect of age on glucose and energy metabolism in brain cortex of rats, Arch. Gerontol. Geriatr. 4:193–203.
Hoyer, S., 1988, Glucose and related brain metabolism in dementia of Alzheimer type and its morphological significane, Age 11:158–166.
Hoyer, S., 1992, Oxidative metabolism in Alzheimer brain. Studies in early-onset and late-onset cases, Mol. Chem. Neuropathol. 16:207–224.
Hoyer, S., 1995, Age-related changes in cerebral oxidative metabolism. Implications for drug therapy, Drugs Aging 6:210–218.
Hoyer, S., 1996, Oxidative metabolism deficiencies in brain of patients with Alzheimer’s disease, Acta Neurol. Scand. Suppl. 165:18–24.
Hoyer, S., 1998, Is sporadic Alzheimer disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesis, J. Neural Transm. 105:415–422.
Hoyer, S., 2002a, The aging brain. Changes in the neuronal insulin/insulin receptor signal transduction cascade trigger late-onset sporadic Alzheimer disease (SAD). A mini-review, J. Neural. Transm. 109:991–1002.
Hoyer, S., 2002b, The brain insulin signal transduction system in sporadic (type II) Alzheimer disease: an update, J. Neural Transm. 109:341–360.
Hoyer, S., and Krier, C, 1986, Ischemia and the aging brain. Studies on glucose and energy metabolism in rat cerebral cortex, Neurobiol. Aging 7:23–29.
Hoyer, S., and Nitsch, R., 1989, Cerebral excess release of neurotransmitter amino acids subsequent to reduced cerebral glucose metabolism in early-onset dementia of Alzheimer type, J Neural. Transm. (Gen. Sect.) 75: 227–232.
Hoyer, S., Nitsch, R., and Oesterreich, K., 1990, Ammonia is endogenously generated in the brain in the presence of presumed and verified dementia of Alzheimer type, Neurosci. Lett. 117:358–362.
Hoyer, S., Nitsch, R., and Oesterreich, K., 1991, Predominant abnormality in cerebral glucose utilization in lateonset dementia of the Alzheimer type: a cross-sectional comparison against advanced late-onset dementia and incipient early-onset cases, J. Neural. Transm. (PD-Sect.) 3:1–14.
Hoyer, S., Lannert, H., Nöldner, M., and Chatterjee, S.S., 1999, Damaged neuronal energy metabolism and behavior are improved by Ginkgo biloba extract (EGb 761), J. Neural. Transm. 106:1171–1188.
Ida, Y., Tanaka, M., Kohno, Y., Nakagawa, R., Iimori, K., Tsuda, A., Hoaki, Y., and Nagasaki, N., 1982, Effects on age and stress on regional noradrenaline metabolism in the rat brain, NeurobioL Aging 3:233–236.
Imaizumi, K., Miyoshi, K., Katayama, T., Yoneda, T., Taniguchi, M., Kudo, T., and Tohyama, M., 2001, The unfolded protein response and Alzheimer’s disease, Biochim. Biophys. Acta 1536:85–96.
Iwata, A., Chen, X.-H., Mclntosh, T.K., Browne, K.D., and Smith, D.H., 2002, Long-term accumulation of amyloid-β in axons following brain trauma without persistent upregulation of amyloid precursor protein genes, J. Neuropathol. Exp. Neurol. 61:1056–1068.
Jiang, C.H., Tsien, J.Z., Schultz, P.G., and Hu, K., 2001, The effects of aging on gene expression in the hypothalamus and cortex of mice, Proc. Natl. Acad. Sci. USA 98:1930–1934.
Jick, H., Zornberg, G.L., Jick, S.S., Seshadri, S., and Drachman, D.A., 2000, Statins and the risk of dementia, Lancet 356:1627–1631.
Joseph, J., Shukitt-Hale, B., Denisova, N.A., Martin, A., Perry, G., and Smith, M.A., 2001, Copernicus revisited: amyloid beta in Alzheimer’s disease, Neurobiol. Aging 22:131–146.
Kadekaro, M., Crane, A.M., and Sokoloff, L., 1985, Differential effects of electrical stimulation of sciatic nerve on metabolic activity in spinal cord and dorsal root ganglion in the rat, Proc. Natl. Acad. Sci. USA 82: 6010–6013.
Kaufer, D., Friedman, A., Seidman, S., and Soreq, H., 1998, Acute stress facilitates long-lasting changes in cholinergic gene expression, Nature 393:373–377.
Kaufman, R.J., 1999, Stress signaling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls, Genes Dev. 13:1211–1233.
Klein, J., 2000, Membrane breakdown in acute and chronic neurodegeneration: focus on choline-containing phospholipids, J. Neural Transm. 107:1027–1063.
Kliegel, M., Rott, C, d’Heureuse, V., Becker, G. and Schönemann, P., 2001, Dementia in the very old is not a necessity: results from the Heidelberg Centenarian Study, Z. Gerontopsychol-psychiatrie 14:169–180.
Lai, J.C.K., and Cooper, A.J.L., 1991, Neurotoxicity of ammonia and fatty acids: differential inhibition of mitochondrial dehydrogenases by ammonia and fatty acyl coenzyme A derivatives, Neurochem. Res. 16: 795–803.
Lannert, H., 1998, Effekte von Streptozotozin, Streptozotozin/Estradiol und Kortikosteron auf Lernverhalten, Gedächtnisfunktion und Energiestoffwechsel im zerebralen Kortex und Hippokampus der adulten männlichen Ratte, Thesis, University of Heidelberg.
Lannert, H., and Hoyer, S., 1998, Intracerebroventricular administration of streptozotocin causes long-term diminutions in learning and memory abilities and in cerebral energy metabolism in adult rats, Behav. Neurosci. 112:1199–1208.
Lannert, H., Gorgas, K., Meißner, I., Wieland, F.T., and Jeckel, D., 1998, Functional organization of the Golgiapparatus in glycosphingolipid biosynthesis: Lactosylceramide and subsequent glycosplingolipids are formed in the lumen of the late Golgi, J. Biol. Chem. 273:2939–2946.
Le Bars, P.L., Katz, M.M., Berman, N., itil, T.M., Freedman, A.M., and Schatzberg, A.F., 1997, A placebocontrolled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group, J. Am. Med. Ass. 278:1327–1332.
Le Bars, P.L., Kieser, M., and Ml, K.Z., 2000, A26-week analysis of a double-blind, placebo-controlled trial of the ginkgo biloba extract EGb 761 in dementia, Dement. Geriatr. Cogn. Disord. 11:230–237.
Leloup, C, Arluison, M., Lepetit, N., Cartier, N., Marfaing-Jallat, P., Ferre, P., and Penicaud, L., 1994, Glucose transporter 2 (GLUT2): expression in specific brain nuclei, Brain Res. 638:221–226.
Leloup, C. Orosco, M., Serradas, P., Nicolaidis, S., and Penicaud, L. 1998, Specific inhibition of GLUT2 in arcuate nucleus by antisense oligonucleotides suppress nervous control of insulin secretion, Mol. Brain Res. 57:275–280.
Löffler, T., Lee, S.K., Nöldner, M., Chatterjee, S.S., Hoyer, S. and Schliebs, R., 2001, Effect of Ginkgo biloba extract (EGb 761) on glucose metabolism-related markers in streptozotocin-damaged rat brain, J. Neural Transm. 108:1457–1474.
Lupien, S., Lecors, A., Lussier, I., Schwartz, G., Nair, N, and Meany, M., 1994, Basal cortisol levels and cognitive deficits in human aging, J. Neurosci. 14:2893–2903.
Mandelkow, E.M., Drewes, G., Biernat, J., Gustke, N., van Lint, J., Vandenheede, J.R., and Mandelkow, E., 1992, Glycogen synthase kinase-3 and the Alzheimer-like state of microtubule-associated protein tau, FEBS Lett. 314:315–321.
Martinez, M., Fernandez, E., Frank, A., Guaza, C, de la Fuente, M., and Hernandez, A., 1999, Increased cerebral spinal fluid cAMP levels in Alzheimer’s disease, Brain Res. 846:265–267.
Mastrogiacomo, F., Bergeron, C, and Kish, S.J., 1993, Brain α-ketoglutarate dehydrogenase complex activity in Alzheimer’s disease, J. Neurochem. 61:2007–2014.
Mauch, D.H., Nägler, K., Schumacher, S., Göritz, E.C., Otto, A., Pfrieger, F.W., 2001, CNS synaptogenesis promoted by glia-derived cholesterol, Science 294:1354–1357.
Michikawa, M., and Yanagisawa, K., 1999, Inhibition of cholesterol production but not of nonsterol isoprenoid products induces neuronal cell death, J. Neurochem. 72:2278–2285.
Mielke, R., Herholz, K., Grond, M., Kessler, J., and Heiss, W.D., 1992, Differences of regional cerebral glucose metabolism between presenile and senile dementia of Alzheimer type, Neurobiol. Aging 13:93–98.
Mirollo, R.E., and Strogatz, S.H., 1990, Synchronization of pulse-coupled biological oscillators, SIAM J. Appl. Math. 50:1645–1649.
Munch, G., Schinzel, R., Loske, C, Wong, A., Durany, N., Li, J.J., Vlassara, H., Smith, M.A., Perry, G., and Riederer P., 1998, Alzheimer’s disease-synergistic effects of glucose deficit, oxidative stress and advanced glycation endproducts, J. Neural Transm. 105:439–462.
Mulder, M., Ravid, R., Swaab, D.,F., de Kloet, E.R., Haasdijk, E.D., Julk, J., van der Boom, J. and Havekes, L.M., 1998, Reduced levels of cholesterol, phospholipids, and fatty acids in cerebrospinal fluid of Alzheimer disease patients are not related to apolipoprotein E4, Alzheimer Dis. Assoc. Disord. 12:198–203.
Nelson, C.A., Wewerka, S., Thomas, K.M., Tribby-Walbridge, S., de Regnier, R., and Georgiff, M., 2000, Neurocognitive sequelae of infants of diabetic mothers, Behav. Neurosci. 114:950–956.
Nitsch, R.M., Blusztajn, J.K., Pittas, A.G., Slack, B.E., Growdon, J.A., and Wurtman, R.J., 1992, Evidence for a membrane defect in Alzheimer disease brain, Proc. Natl. Acad. Sci. USA 89:1671–1675.
Okada, M., Ishikawa, M., and Mizushima, Y., 1991, Identification of a ubiquitin-and ATP-dependent protein degradation in rat cerebral cortex, Biochim. Biophys. Acta 1073:514–520.
Ott, A., Breteler, M.M.B., van Harskamp, F., Claus, J.J., van der Cammen, T.J.M., Grobbee, D.E., and Hofman, A., 1995, Prevalence of Alzheimer’s disease and vascular dementia: association with education. The Rotterdam study, Br. J. Med. 310:970–973.
Papenberg, J., Lanzinger, G., Kommerell, B., and Hoyer, S., 1975, Comparative studies of the electroencephalogram and the cerebral oxidative metabolism in patients with liver cirrhosis, Klin. Wschr. 53:1107–1113.
Peraldi, P., Hotamisligil, G.S., Buurman, W.A., White, M.F., and Spiegelman, B.M., 1996, Tumor necrosis factor (TNF)-α inhibits insulin signaling through stimulation of the p55TNF receptor and activation of sphingomyelinase, J. Biol. Chem. 271:13018–13022.
Perego, C, Vetrugno, C.C., De Simoni, M.G., and Algeri, S., 1993, Aging prolongs the stress-induced release ofnoradrenaline in rat hypothalamus, Neurosci. Lett. 157:127–130.
Pericak-Vance, M.A., Grubber, J., Bailey, L.R., Hedges, D., West, S., Sentoro, L., Kemmerer, B., Hall, J.L., Saunders, A.M., Roses, A.D., et al. 2000, Identification of novel genes in late-onset Alzheimer’s disease, Exp. Gerontol. 35:1343–1352.
Perlmutter, D.H., 1999, Misfolded proteins in the endoplasmine reticulum, Lab. Invest. 79:623–638.
Perry, E.K., Perry, R.H., Tomlinson, B.E., Blessed, G., and Gibson, P.H., 1980, Coenzyme A-acetylating enzymes in Alzheimer’s disease: possible cholinergic „compartment“ of pyruvate dehydrogenase, Neurosci. Lett. 18:105–110.
Peskind, E.R., Elrod, R., Dobie, D.J., Pascualy, M., Petrie, E., Jensen, C, Brodkin, K., Murray, S., Veith, R.C., and Raskind, M.A., 1998, Cerebrospinal fluid epinephrine in Alzheimer’s disease and normal aging, Neuropsychopharmacology 19:465–471.
Pettegrew, J.W., Klunk, W.E., Kanal, E., Panchalingam, K., and McClure, R.J., 1995, Changes in brain membrane phospholipid and high-energy phosphate metabolism precede dementia, Neurobiol. Aging 16: 973–975.
Plaschke, K., and Hoyer, S., 1993, Action of the diabetogenic drug streptozotocin on glycolytic and glycogenolytic metabolism in adult rat brain cortex and hippocampus, Int. J. Devl. Neurosci. 11:477–483.
Prigogine, I., 1989, What is entropy?, Naturwissenschaften 76:1–8.
Reul, J.M.H.M., Rothuizen, J., and Dekloet, E.R., 1991, Age-related changes in the dog hypothalamic-pituitary-adrenocortical system: neuroendocrine activity and corticosteroid receptors, J. Steroid. Biochem. Molec. Biol. 40:63–69.
Roberts, E.L. jr., and Sick, T.J., 1996, Aging impairs regulation of intracellular pH in rat hippocampal slices, Brain Res. 735:339–342.
Róder, H.M., and Ingram, V.M., 1991, Two novel kinases phosphorylate tau and the KSP site of heavy neurofilament subunits in high stoichiometric ratios, J. Neurosci. 11:3325–3342.
Rothman, J.E., 1996, The protein machinery of vesicle budding and fusion, Protein Science 5:185–194.
Rothman, J.E., and Wieland, F.T., 1996, Protein sorting by transport vesicles. Science 272:227–234.
Rupprecht, R., and Holsboer, F., 1999, Neuroactive steroids: mechanism of action and neuropsychopharmacological perspectives, Trends Neurosci. 22:410–416.
Sacks, W., 1957, Cerebral metabolism of isotopic glucose in normal human subjects, J. Appl. Physiol. 10:37–44.
Sacks, W., 1965, Cerebral metabolism of doubly labelled glucose in human in vivo, J. Appl. Physiol. 20:117–130.
Salehi, A., and Swaab, D.F., 1999, Diminished neuronal metabolic activity in Alzheimer’s disease, J. Neural Transm. 106:955–986.
Salehi, A., Heyn, S., Gonatas, N.K., and Swaab, D.F., 1995, Decreased protein synthetic activity of the hypothalamic tubero mamillary nucleus in Alzheimer’s disease as suggested by smaller Golgi apparatus, Neurosci. Lett. 193:29–32.
Salehi, A., Lucassen, P.J., Pool, C.W., Gonatas, N.K., Ravid, R., and Swaab, D.F., 1994, Decreased neuronal activity in the nucleus basalis of Meynert in Alzheimer’s disease as suggested by the size of the Golgi apparatus, Neuroscience 59:871–880.
Sapolsky, R.M., 1994, Glucocorticoids, stress and exacerbation of excitotoxic neuron death, Sem. Neurosci. 6: 323–331.
Sapolsky, R.M., 1998, The stress of Gulf War syndrome, Nature 393:308–309.
Sapolsky, R.M., Krey, L.C., and McEwen, B.S., 1983, The adrenocortical stress-response in the aged malge rat: impairment of recovery from stress, Exp. Gerontol. 18:55–64.
Sapolsky, R.M., Krey, L.C., and McEwen, B.S., 1986, The neuroendocrinology of stress and aging. The glucocorticoid cascade hypothesis, Endocr. Res. 7:284–301.
Sapolsky, R.M., Zola-Morgan, S., and Squire, L.R., 1991, Inhibition of glucocorticoid secretion by the hippocampal formation in the primate, J. Neurosci. 11:3695–3704.
Seksek, O., Biwersi, J., and Verkman, A.S., 1995, Direct measurement of trans-Golgi pH in living cells and regulation by second messengers, J. Biol. Chem. 270:4967–4970.
Simons, M., Keller, P., de Strooper, B., Beyreuther, K., Dotti, C, and Simons, K., 1998, Cholesterol depletion inhibits the generation of β-amyloid in hippocampal neurons, Proc. Natl. Acad. Sci. USA 95:6460–6464.
Simons, M., Schwärzler, I., Lütjohann, D., von Bergmann, K., Beyreuther, K., Dichgans, J., Wormstall, H., Hartmann, T., and Schulz, J.B., 2002, Treatment with simvastatin in normocholesterolemic patients with Alzheimer’s disease: A 26-week randomized, placebo-controlled, double-blind trial, Ann. Neurol. 52:346–350.
Sims, N.R., Bowen, D.M., Allen, S.J., Smith, C.C.T., Neary, D., Thomas, D.J., and Davison, A.N., 1983a, Presynaptic cholinergic dysfunction in patients with dementia, J. Neurochem. 40:503–509.
Sims, N.R., Bowen, D.M., Neary, D., and Davison, A.N., 1983b, Metabolic processes in Alzheimer’s disease: adenine nucleotide content and production of 14CO2 from (U14 C) glucose in vitro in human neocortex, J. Neurochem. 41:1329–1334.
Singh, H., Usher, S., and Poulos, A., 1989, Mitochondrial and peroxisomal beta-oxidation of stearic and lignoceric acids by rat brain, J. Neurochem. 53:1711–1718.
Solano, D.C., Sironi, M., Bonfini, C, Solerte, S.B., Govoni, S., and Racchi, M., 2000, Insulin regulates soluble amyloid precursor protein release via phosphatidyl inositol 3 kinase-dependent pathway, FASEB J. 14: 1015–1022.
Sorbi, S., Bird, E.D., and Blass, J.P., 1983, Decreased pyruvate dehydrogenase complex activity in Huntington and Alzheimer brain, Ann. Neurol. 13:72–78.
Svennerholm, L., and Gottfries, C.G., 1994, Membrane lipids, selectively diminished in Alzheimer brains, suggest synapse loss as a primary event in early-onset form (type I) and demyelination in late-onset form (type II), J. Neurochem. 62:1039–1047.
Swaab, D.F., Raadsheer, F.C., Endert, E.F., Hofman, M.A., Kamphorst, W.C., and Ravid, R., 1994, Increases in cortisol levels in aging and Alzheimer’s disease in postmortem cerebrospinal fluid, Neuroendocrinology 6: 681–687.
Takahashi, L.K., 1998, Prenatal stress: Consequences of glucocorticoids on hippocampal development and function, Int. J. Devl. Neurosci. 16:199–207.
Taubes, G., 1996, Misfolding the way to disease, Science 271:1493–1495.
Thomas, P.J., Qu, B.-H., and Pedersen, P.L., 1995, Defective protein folding as a basis of human disease, Trends Biol. Sci. 20:456–459.
Vallée, M., Maccari, S., Delhi, F., Simon, H., LeMoal, M., and Mayo, W., 1999, Long-term effects of prenatal stress and postnatal handling on age-related glucocorticoid secretion and cognitive performance: a longitudinal study in the rat, Eur. J. Neurosci. 11:2906–2916.
Valverde, A.M., Teruel, T., Navarro, P., Benito, M., and Lorenzo, M., 1998, Tumor necrosis factor-α causes insulin receptor substrate-2-mediated insulin resistence and inhibits insulin-induced adipogenesis in fetal brown adipocytes, Endodrinology 139:1229–1238.
Verde, C, Pascale, M.C., Martive, G., Lotti, L.V., Torrisi, M.R., Helenius, A., and Bonatti, S., 1995, Effect of ATP depletion and DTT on the transport of membrane proteins from the endoplasmic reticulum and the intermediate compartment to the Golgi complex, Eur. J. Cell Biol. 67:267–274.
Virgin, C.E. jr., Ha, T.P.T., Packan, D.R., Tombaugh, G.C. Yang, S.H., Homer, H.C., and Sapolsky, R.M., 1991, Glucocorticoids inhibit glucose transport and glutamate uptake in hippocampal astrocytes: implications for glucocorticoid neurotoxicity, J. Neurochem. 57:1422–1428.
von der Kammer, H., Mayhaus, M., Albrecht, C, Enderich, J. Wegner, M., and Nitsch, R.M., 1998, Muscarinic acetylcholine receptors activate expression of the Egr gene family of transcription factors, J. Biol. Chem. 273:14538–14544.
Watanabe, C.M.H., Wolffram, S., Ader, P., Rimbach, G., Packer, L., Maguire, J.J., Schultz, P.G., and Gohil, K., 2001, The in vivo neuromodulatory effects of the herbal medicine ginkgo biloba, Proc. Natl. Acad. Sci. USA 98:6577–6580.
Wolozin, B., Kellman, W., Ruosseau, P., Celesia, G.G., and Siegel, 2000, Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methylglutaryl Coenzmye A reductase inhibitors, Arch. Neurol. 57: 1439–1443.
Wozniak, M., Rydzewski, B., Baker, S.P., and Raizada, M.K., 1993, The cellular and physiological actions of insulin in the central nervous system, Neurochem. Int. 22:1–10.
Wurtman, R.J., 1992, Choline metabolism as a basis for the selective vulnerability of cholinergic neurons, Trends Neurosci. 15:117–122.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer Science+Business Media New York
About this paper
Cite this paper
Hoyer, S. (2004). Causes and Consequences of Disturbances of Cerebral Glucose Metabolism in Sporadic Alzheimer Disease: Therapeutic Implications. In: Vécsei, L. (eds) Frontiers in Clinical Neuroscience. Advances in Experimental Medicine and Biology, vol 541. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-8969-7_8
Download citation
DOI: https://doi.org/10.1007/978-1-4419-8969-7_8
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-4740-8
Online ISBN: 978-1-4419-8969-7
eBook Packages: Springer Book Archive